Fundraising Fox
D2B3
New Haven, US · 4 employees on LinkedIn · 1 known investors
Find your way into D2B3
Sign up to see every warm intro you have to D2B3
- Paths you didn't know you had: your email and LinkedIn already hold routes to the D2B3 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
D2B3 develops proprietary drug delivery technology that temporarily relaxes the blood-brain barrier to enable therapeutic targeting of central nervous system diseases. The platform is designed to work across multiple drug classes for treating brain-related disorders.
Investors · 1
Frequently asked questions
- What does D2B3 do?
- D2B3 develops proprietary drug delivery technology that temporarily relaxes the blood-brain barrier to enable therapeutic targeting of central nervous system diseases. The platform is designed to work across multiple drug classes for treating brain-related disorders.
- Who are D2B3's investors?
- D2B3's investors include Connecticut Innovations.
- Where is D2B3 headquartered?
- D2B3 is headquartered in New Haven, US.